Digital Pathology Market Size, Share & Trends by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered
1.3.3 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Approach
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.2 Research Methodology Design
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions
2.6 Market Assumptions
2.6.1 Overall Study Assumptions
2.7 Risk Assessment
2.8 Research Limitations
2.8.1 Methodology-Related Limitations
2.8.2 Scope-Related Limitations

4.1 Digital Pathology Market Overview
4.2 North America: Digital Pathology Market, by End-user & Country (2023)
4.3 Digital Pathology Market: Geographic Growth Opportunities
4.4 Digital Pathology Market: Regional Mix

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Cancer and Chronic Diseases
5.2.1.2 Increasing Adoption of Digital Pathology Solutions to Enhance Lab Efficiency
5.2.1.3 Growing Applications in Drug Development and Companion Diagnostics
5.2.1.4 Rising Awareness of Early Cancer Diagnosis in Emerging Markets
5.2.2 Restraints
5.2.2.1 High Cost of Digital Pathology Systems
5.2.3 Opportunities
5.2.3.1 Introduction of Affordable Scanners for Private Pathology Practices
5.2.3.2 Growing Preference for Personalized Medicine
5.2.3.3 High Growth Potential of Emerging Economies
5.2.4 Challenges
5.2.4.1 Shortage of Skilled Pathologists
5.3 Industry Trends
5.3.1 Telepathology
5.3.2 Multiplexing
5.4 Technology Analysis
5.4.1 Key Technologies
5.4.1.1 AI in Digital Pathology
5.4.1.2 Label-Free Imaging in Digital Pathology
5.4.1.3 Computational Image Analysis in Digital Pathology
5.4.2 Adjacent Technologies
5.4.2.1 Genomic Sequencing
5.4.3 Complementary Technologies
5.4.3.1 Molecular Imaging
5.5 Pricing Analysis
5.5.1 Average Selling Price Trend, by Region
5.5.2 Average Selling Price Trend of Key Players, by Product
5.6 Value Chain Analysis
5.7 Ecosystem Analysis
5.8 Porter's Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Threat of Substitutes
5.8.3 Bargaining Power of Suppliers
5.8.4 Bargaining Power of Buyers
5.8.5 Intensity of Competitive Rivalry
5.9 Regulatory Landscape
5.9.1 Regulatory Bodies, Government Agencies, And Other Organizations
5.9.2 Regulatory Analysis
5.9.2.1 North America
5.9.2.1.1 US
5.9.2.1.2 Canada
5.9.2.2 Europe
5.9.2.3 Asia-Pacific
5.9.2.3.1 Japan
5.9.2.3.2 China
5.9.2.3.3 India
5.10 HS Codes for Digital Pathology Scanners
5.11 Patent Analysis
5.11.1 Patent Publication Trends
5.11.2 Jurisdiction Analysis: Top Applicant Countries for Digital Pathology Patents
5.11.3 Major Patents
5.12 Case Study Analysis
5.13 Key Conferences & Events, 2024-2025
5.14 Key Stakeholders & Buying Criteria
5.14.1 Key Stakeholders in Buying Process
5.14.2 Buying Criteria
5.15 End-user Analysis
5.15.1 Unmet Needs
5.15.2 End-user Expectations
5.16 Business Model Analysis
5.17 Investment & Funding Scenario
5.18 Impact of Generative AI on Digital Pathology Market
5.18.1 Top Use Cases & Market Potential
5.18.1.1 Key Use Cases
5.18.2 Case Studies of Generative AI Implementation
5.18.2.1 Case Study 1: Healthcare - Enhancing Medical Imaging
5.18.2.2 Case Study 2: Combining Generative AI with Biosensors and Lab-On-A-Chip Technology
5.18.2.3 Case Study 3: Impact of Gen AI-based Digital Pathology: The Korean Experience
5.18.2.4 AI in Pathology Market
5.18.2.5 Tissue Diagnostics Market
5.18.2.6 Anatomic Pathology Market
5.18.3 User Readiness and Impact Assessment
5.18.3.1 User Readiness
5.18.3.1.1 Pharmaceutical & Biotechnology Companies
5.18.3.1.2 Hospitals & Reference Laboratories
5.18.3.1.3 Academic & Research Institutes
5.18.3.2 Impact Assessment
5.18.3.2.1 Pharmaceutical & Biotechnology Companies
5.18.3.2.2 Hospitals & Reference Laboratories
5.18.3.2.3 Academic & Research Institutes

6.1 Introduction
6.2 Scanners
6.2.1 Brightfield Scanners
6.2.1.1 Cost-Efficient Features to Boost Demand
6.2.2 Fluorescence Scanners
6.2.2.1 Ability to Detect Cellular Structures and Biomarkers to Fuel Uptake
6.2.3 Other Scanners
6.3 Software, by Type
6.3.1 Integrated Software
6.3.1.1 Single & Effective Suite for Multiple Applications to Propel Market
6.3.2 Standalone Software
6.3.2.1 Information Management Software
6.3.2.1.1 Management of Image Repositories to Fuel Uptake
6.3.2.2 Image Analysis Software
6.3.2.2.1 Ability to Automate Quantitative Evaluation to Support Market Growth
6.4 Software, by Deployment Model
6.4.1 Cloud-based Model
6.4.1.1 Benefits of Cloud-based Models and Ease of Access to Drive Market
6.4.2 On-Premise Model
6.4.2.1 High Data Security and Integration with Hcit Solutions to Fuel Uptake
6.4.3 Hybrid Model
6.4.3.1 Combined Flexibility to Support Market Growth
6.5 Storage Systems
6.5.1 Growing Focus on Storage of High-Resolution Images to Drive Market

7.1 Introduction
7.2 Human Pathology
7.2.1 Increasing Cancer Research Activities to Propel Market
7.3 Veterinary Pathology
7.3.1 Improvements in Animal Disease Diagnostics to Support Market Growth

8.1 Introduction
8.2 Drug Discovery
8.2.1 Increasing Focus on Life Sciences R&D to Drive Market
8.3 Disease Diagnosis
8.3.1 Integration of AI & ML in Complex Diagnostics to Boost Demand
8.4 Training & Education
8.4.1 Ability to Provide Real-Time Learning Experiences to Support Market Growth

9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.2.1 Increasing Focus on Drug Toxicology Testing and Rising Number of Preclinical Trials to Propel Market
9.3 Hospitals and Reference Laboratories
9.3.1 High Incidence of Infectious Diseases to Boost Demand
9.4 Academic & Research Institutes
9.4.1 Increasing Public & Private Funding Investments to Support Market Growth

10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Favorable Reimbursements for Diagnostics to Drive Market
10.2.2 Canada
10.2.2.1 Growing Awareness of Early Cancer Detection & Diagnosis to Drive Market
10.3 Europe
10.3.1 Germany
10.3.1.1 High Healthcare Expenditure and Supportive Research Initiatives to Drive Market
10.3.2 UK
10.3.2.1 Government Funding Investments for Pathology Services to Fuel Market
10.3.3 Sweden
10.3.3.1 Increasing Prevalence of Chronic Diseases to Support Market Growth
10.3.4 Denmark
10.3.4.1 Increasing Deployment of Digital Pathology Solutions to Support Market Growth
10.3.5 France
10.3.5.1 Increasing Government Funding and Favorable Insurance System to Drive Adoption
10.3.6 Spain
10.3.6.1 Supportive Collaborations Among Leading Companies and Hospitals to Boost Demand
10.3.7 Italy
10.3.7.1 Integration of AI & ML to Support Market Growth
10.3.8 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.1.1 Increasing Establishment of Hospitals and Reference Laboratories to Drive Market
10.4.2 Japan
10.4.2.1 Advanced Healthcare Infrastructure to Support Market Growth
10.4.3 India
10.4.3.1 Growth in Pharmaceutical Industry to Propel Market
10.4.4 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 High Adoption of Poc Testing to Drive Market
10.5.2 Mexico
10.5.2.1 Growth in Companion Diagnostics to Fuel Uptake
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Improvements in Healthcare Infrastructure to Support Market Growth
10.6.2 GCC Countries
10.6.3 Rest of Middle East & Africa

11.1 Overview
11.2 Key Player Strategy/Right to Win
11.2.1 Overview of Strategies Adopted by Players in Digital Pathology Market
11.3 Revenue Analysis
11.4 Market Share Analysis
11.5 Company Evaluation Matrix: Key Players, 2023
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Company Footprint: Key Players, 2023
11.5.5.1 Product Footprint
11.5.5.2 Application Footprint
11.5.5.3 End-user Footprint
11.5.5.4 Region Footprint
11.6 Company Evaluation Matrix: Startups/SMEs, 2023
11.6.1 Progressive Companies
11.6.2 Responsive Companies
11.6.3 Dynamic Companies
11.6.4 Starting Blocks
11.6.5 Competitive Benchmarking: Startups/SMEs, 2023
11.7 Valuation & Financial Metrics
11.8 Brand/Software Comparative Analysis
11.9 Competitive Scenario
11.9.1 Product Launches, Enhancements, and Approvals
11.9.2 Deals
11.9.3 Other Developments

12.1 Key Companies
12.1.1 Danaher Corporation
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Product Enhancements
12.1.1.4 Analyst's View
12.1.1.4.1 Key Strengths
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses and Competitive Threats
12.1.2 Koninklijke Philips N.V.
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Product Launches
12.1.2.3.2 Deals
12.1.2.4 Analyst's View
12.1.2.4.1 Key Strengths
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses and Competitive Threats
12.1.3 Hamamatsu Photonics K.K.
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Product Approvals
12.1.3.3.2 Deals
12.1.3.4 Analyst's View
12.1.3.4.1 Key Strengths
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses and Competitive Threats
12.1.4 F. Hoffmann-La Roche Ltd.
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Product Launches & Approvals
12.1.4.3.2 Deals
12.1.4.4 Analyst's View
12.1.4.4.1 Key Strengths
12.1.4.4.2 Strategic Choices
12.1.4.4.3 Weaknesses and Competitive Threats
12.1.5 Sectra Ab
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Deals
12.1.5.3.2 Other Developments
12.1.5.4 Analyst's View
12.1.5.4.1 Key Strengths
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses and Competitive Threats
12.1.6 Akoya Biosciences, Inc.
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Product Launches & Approvals
12.1.6.3.2 Deals
12.1.7 Fujifilm Holdings Corporation
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.7.3 Recent Developments
12.1.7.3.1 Deals
12.1.8 Hologic, Inc.
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.8.3 Recent Developments
12.1.8.3.1 Product Approvals
12.1.9 3Dhistech Ltd.
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Product Launches & Enhancements
12.1.9.3.2 Other Developments
12.1.10 Apollo Enterprise Imaging Corp.
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.10.3 Recent Developments
12.1.10.3.1 Product Enhancements
12.1.10.3.2 Deals
12.1.11 Xifin, Inc.
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.11.3 Recent Developments
12.1.11.3.1 Product Launches
12.1.11.3.2 Deals
12.1.12 Huron Digital Pathology
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.12.3 Recent Developments
12.1.12.3.1 Product Approvals
12.1.12.3.2 Deals
12.1.12.3.3 Other Developments
12.1.13 Corista
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.13.3 Recent Developments
12.1.13.3.1 Deals
12.1.13.3.2 Other Developments
12.1.14 Indica Labs
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.14.3 Recent Developments
12.1.14.3.1 Product Launches & Approvals
12.1.14.3.2 Deals
12.1.15 Objective Pathology Services
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.1.16 Optrascan, Inc.
12.1.16.1 Business Overview
12.1.16.2 Products Offered
12.1.16.3 Recent Developments
12.1.16.3.1 Product Launches & Approvals
12.1.16.3.2 Deals
12.1.17 Glencoe Software, Inc.
12.1.17.1 Business Overview
12.1.17.2 Products Offered
12.1.17.3 Recent Developments
12.1.17.3.1 Product Enhancements
12.1.18 Aiforia Technologies Oy
12.1.18.1 Business Overview
12.1.18.2 Products Offered
12.1.18.3 Recent Developments
12.1.18.3.1 Deals
12.1.19 Paige AI, Inc.
12.1.19.1 Business Overview
12.1.19.2 Products Offered
12.1.19.3 Recent Developments
12.1.19.3.1 Product Launches & Enhancements
12.1.19.3.2 Deals
12.1.20 Proscia, Inc.
12.1.20.1 Business Overview
12.1.20.2 Products Offered
12.1.20.3 Recent Developments
12.1.20.3.1 Product Enhancements & Approvals
12.1.20.3.2 Deals
12.2 Other Players
12.2.1 Pathai
12.2.2 Konfoong Biotech International Co. Ltd.
12.2.3 Mikroscan Technologies, Inc.
12.2.4 Motic Digital Pathology
12.2.5 Kanteron Systems
12.2.6 Morphle Labs Inc.

13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Table 1 Factor Analysis
Table 2 Risk Assessment
Table 3 Incidence of Cancer, by Region, 2020 vs. 2030 vs. 2040 (Million)
Table 4 US: Growth in Number of Personalized Medicines (2008-2020)
Table 5 Number of Inhabitants Per Pathologist, by Country, 2020
Table 6 Average Selling Price Trend of Digital Pathology Products, by Region
Table 7 Average Selling Price of Digital Pathology Products
Table 8 Digital Pathology Market: Porter's Five Forces
Table 9 Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 US FDA: Medical Device Classification
Table 11 US: Medical Device Regulatory Approval Process
Table 12 Canada: Medical Device Regulatory Approval Process
Table 13 Europe: Classification of Ivd Devices
Table 14 Japan: Medical Device Classification Under Pmda
Table 15 China: Classification of Medical Devices
Table 16 HS Code: Digital Pathology Scanner
Table 17 Case Study 1: Assessing Image Quality for Comparative Multi-Assessment Evaluation of Aperio Gt 450 Dx
Table 18 Case Study 2: Promotion of Pathology Workflow Efficiency
Table 19 Case Study 3: Integration of Artificial Intelligence in Digital Pathology
Table 20 Digital Pathology Market: Key Conferences & Events, 2024-2025
Table 21 Stakeholders in Buying Process: Definitions
Table 22 Influence of Stakeholders on Buying Process for Digital Pathology, by Product
Table 23 Key Buying Criteria for Digital Pathology Products
Table 24 Unmet Needs in Digital Pathology Market
Table 25 End-user Expectations in Digital Pathology Market
Table 26 Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 27 Scanning Magnification and Applications
Table 28 Digital Pathology Scanners Offered by Key Market Players
Table 29 Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 30 Digital Pathology Market for Scanners, by Country, 2022-2029 (USD Million)
Table 31 Brightfield Scanners Offered by Key Market Players
Table 32 Brightfield Scanners Market, by Country, 2022-2029 (USD Million)
Table 33 Fluorescence Scanners Offered by Key Market Players
Table 34 Fluorescence Scanners Market, by Country, 2022-2029 (USD Million)
Table 35 Other Scanners Offered by Key Market Players
Table 36 Other Scanners Market, by Country, 2022-2029 (USD Million)
Table 37 Digital Pathology Software Offered by Key Market Players
Table 38 Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 39 Digital Pathology Market for Software, by Country, 2022-2029 (USD Million)
Table 40 Integrated Software Offered by Key Market Players
Table 41 Integrated Software Market, by Country, 2022-2029 (USD Million)
Table 42 Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 43 Standalone Software Market, by Country, 2022-2029 (USD Million)
Table 44 Information Management Software Offered by Key Market Players
Table 45 Information Management Software Market, by Country, 2022-2029 (USD Million)
Table 46 Image Analysis Software Offered by Key Market Players
Table 47 Image Analysis Software Market, by Country, 2022-2029 (USD Million)
Table 48 Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 49 Cloud-based Software Offered by Key Market Players
Table 50 Cloud-based Model Market, by Country, 2022-2029 (USD Million)
Table 51 On-Premise Software Offered by Key Market Players
Table 52 On-Premise Model Market, by Country, 2022-2029 (USD Million)
Table 53 Hybrid Software Offered by Key Market Players
Table 54 Hybrid Model Market, by Country, 2022-2029 (USD Million)
Table 55 Storage Systems Offered by Key Market Players
Table 56 Digital Pathology Market for Storage Systems, by Country, 2022-2029 (USD Million)
Table 57 Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 58 Human Digital Pathology Market, by Country, 2022-2029 (USD Million)
Table 59 Veterinary Digital Pathology Market, by Country, 2022-2029 (USD Million)
Table 60 Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 61 Software Impact Analysis, by Application
Table 62 Digital Pathology Applications in Drug Discovery
Table 63 Digital Pathology Market for Drug Discovery, by Country, 2022-2029 (USD Million)
Table 64 Digital Pathology Market for Disease Diagnosis, by Country, 2022-2029 (USD Million)
Table 65 Digital Pathology Market for Training & Education, by Country, 2022-2029 (USD Million)
Table 66 Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 67 Software Impact Analysis, by End-user
Table 68 Digital Pathology Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 69 Deployment of Digital Pathology Solutions in Hospitals
Table 70 Digital Pathology Market for Hospitals and Reference Laboratories, by Country, 2022-2029 (USD Million)
Table 71 Digital Pathology Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 72 Digital Pathology Market, by Region, 2022-2029 (USD Million)
Table 73 North America: Digital Pathology Market, by Country, 2022-2029 (USD Million)
Table 74 North America: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 75 North America: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 76 North America: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 77 North America: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 78 North America: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 79 North America: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 80 North America: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 81 North America: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 82 US: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 83 US: Key Macroindicators
Table 84 US: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 85 US: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 86 US: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 87 US: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 88 US: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 89 US: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 90 US: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 91 US: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 92 Canada: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 93 Canada: Funding Initiatives for Digital Pathology
Table 94 Canada: Key Macroindicators
Table 95 Canada: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 96 Canada: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 97 Canada: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 98 Canada: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 99 Canada: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 100 Canada: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 101 Canada: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 102 Canada: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 103 Europe: Digital Pathology Market, by Country, 2022-2029 (USD Million)
Table 104 Europe: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 105 Europe: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 106 Europe: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 107 Europe: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 108 Europe: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 109 Europe: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 110 Europe: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 111 Europe: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 112 Germany: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 113 Germany: Key Macroindicators
Table 114 Germany: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 115 Germany: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 116 Germany: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 117 Germany: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 118 Germany: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 119 Germany: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 120 Germany: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 121 Germany: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 122 UK: Cancer Incidence, by Type, 2020 vs. 2040
Table 123 UK: Key Macroindicators
Table 124 UK: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 125 UK: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 126 UK: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 127 UK: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 128 UK: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 129 UK: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 130 UK: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 131 UK: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 132 Sweden: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 133 Sweden: Key Macroindicators
Table 134 Sweden: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 135 Sweden: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 136 Sweden: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 137 Sweden: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 138 Sweden: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 139 Sweden: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 140 Sweden: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 141 Sweden: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 142 Denmark: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 143 Denmark: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 144 Denmark: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 145 Denmark: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 146 Denmark: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 147 Denmark: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 148 Denmark: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 149 Denmark: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 150 Denmark: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 151 France: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 152 France: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 153 France: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 154 France: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 155 France: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 156 France: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 157 France: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 158 France: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 159 France: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 160 Spain: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 161 Spain: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 162 Spain: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 163 Spain: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 164 Spain: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 165 Spain: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 166 Spain: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 167 Spain: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 168 Italy: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 169 Italy: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 170 Italy: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 171 Italy: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 172 Italy: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 173 Italy: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 174 Italy: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 175 Italy: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 176 Rest of Europe: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 177 Rest of Europe: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 178 Rest of Europe: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 179 Rest of Europe: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 180 Rest of Europe: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 181 Rest of Europe: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 182 Rest of Europe: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 183 Rest of Europe: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 184 Asia-Pacific: Digital Pathology Market, by Country, 2022-2029 (USD Million)
Table 185 Asia-Pacific: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 186 Asia-Pacific: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 187 Asia-Pacific: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 188 Asia-Pacific: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 189 Asia-Pacific: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 190 Asia-Pacific: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 191 Asia-Pacific: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 192 Asia-Pacific: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 193 China: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 194 China: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 195 China: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 196 China: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 197 China: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 198 China: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 199 China: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 200 China: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 201 China: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 202 Japan: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 203 Japan: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 204 Japan: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 205 Japan: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 206 Japan: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 207 Japan: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 208 Japan: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 209 Japan: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 210 Japan: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 211 India: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 212 India: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 213 India: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 214 India: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 215 India: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 216 India: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 217 India: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 218 India: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 219 India: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 220 Rest of Asia-Pacific: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 221 Rest of Asia-Pacific: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 222 Rest of Asia-Pacific: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 223 Rest of Asia-Pacific: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 224 Rest of Asia-Pacific: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 225 Rest of Asia-Pacific: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 226 Rest of Asia-Pacific: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 227 Rest of Asia-Pacific: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 228 Latin America: Digital Pathology Market, by Country, 2022-2029 (USD Million)
Table 229 Latin America: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 230 Latin America: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 231 Latin America: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 232 Latin America: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 233 Latin America: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 234 Latin America: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 235 Latin America: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 236 Latin America: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 237 Brazil: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 238 Brazil: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 239 Brazil: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 240 Brazil: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 241 Brazil: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 242 Brazil: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 243 Brazil: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 244 Brazil: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 245 Brazil: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 246 Mexico: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 247 Mexico: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 248 Mexico: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 249 Mexico: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 250 Mexico: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 251 Mexico: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 252 Mexico: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 253 Mexico: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 254 Mexico: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 255 Rest of Latin America: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 256 Rest of Latin America: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 257 Rest of Latin America: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 258 Rest of Latin America: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 259 Rest of Latin America: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 260 Rest of Latin America: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 261 Rest of Latin America: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 262 Rest of Latin America: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 263 Middle East & Africa: Digital Pathology Market, by Country, 2022-2029 (USD Million)
Table 264 Middle East & Africa: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 265 Middle East & Africa: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 266 Middle East & Africa: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 267 Middle East & Africa: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 268 Middle East & Africa: Digital Pathology Market for Software, by Deployment Model, 2022-2029 (USD Million)
Table 269 Middle East & Africa: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 270 Middle East & Africa: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 271 Middle East & Africa: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 272 GCC Countries: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 273 GCC Countries: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 274 GCC Countries: Digital Pathology Market for Software, by Type, 2022-2029 (USD Million)
Table 275 GCC Countries: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 276 GCC Countries: Digital Pathology Market for Software, by Deployment Mode, 2022-2029 (USD Million)
Table 277 GCC Countries: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 278 GCC Countries: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 279 GCC Countries: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 280 Rest of Middle East & Africa: Digital Pathology Market, by Product, 2022-2029 (USD Million)
Table 281 Rest of Middle East & Africa: Digital Pathology Market for Scanners, by Type, 2022-2029 (USD Million)
Table 282 Rest of Middle East & Africa: Digital Pathology Market For Software, by Type, 2022-2029 (USD Million)
Table 283 Rest of Middle East & Africa: Standalone Software Market, by Type, 2022-2029 (USD Million)
Table 284 Rest of Middle East & Africa: Digital Pathology Market For Software, by Deployment Model, 2022-2029 (USD Million)
Table 285 Rest of Middle East & Africa: Digital Pathology Market, by Type, 2022-2029 (USD Million)
Table 286 Rest of Middle East & Africa: Digital Pathology Market, by Application, 2022-2029 (USD Million)
Table 287 Rest of Middle East & Africa: Digital Pathology Market, by End-user, 2022-2029 (USD Million)
Table 288 Overview of Strategies Deployed by Key Manufacturing Companies
Table 289 Digital Pathology Market: Degree of Competition
Table 290 Digital Pathology Market: Product Footprint
Table 291 Digital Pathology Market: Application Footprint
Table 292 Digital Pathology Market: End-user Footprint
Table 293 Digital Pathology Market: Region Footprint
Table 294 Digital Pathology Market: Detailed List of Key Start-Ups/SMEs
Table 295 Digital Pathology Market: Competitive Benchmarking of Key Emerging Players/Startups
Table 296 Digital Pathology Market: Product Launches, Enhancements, And Approvals, January 2021-March 2024
Table 297 Digital Pathology Market: Digital Pathology Market: Deals, January 2021-March 2024
Table 298 Digital Pathology Market: Other Developments, January 2021-March 2024
Table 299 Danaher Corporation: Company Overview
Table 300 Danaher Corporation: Products Offered
Table 301 Danaher Corporation: Product Enhancements, January 2021-June 2024
Table 302 Koninklijke Philips N.V.: Company Overview
Table 303 Koninklijke Philips N.V.: Products Offered
Table 304 Koninklijke Philips N.V: Product Launches, January 2021-June 2024
Table 305 Koninklijke Philips N.V.: Deals, January 2021-June 2024
Table 306 Hamamatsu Photonics K.K.: Company Overview
Table 307 Hamamatsu Photonics K.K.: Products Offered
Table 308 Hamamatsu Photonics K.K.: Product Approvals, January 2021-June 2024
Table 309 Hamamatsu Photonics K.K.: Deals, January 2021-June 2024
Table 310 F. Hoffmann-La Roche Ltd.: Company Overview
Table 311 F. Hoffmann-La Roche Ltd.: Products Offered
Table 312 Hoffmann-La Roche Ltd.: Product Launches & Approvals, January 2021-June 2024
Table 313 Hoffmann-La Roche Ltd.: Deals, January 2021-June 2024
Table 314 Sectra Ab: Company Overview
Table 315 Sectra Ab: Products Offered
Table 316 Sectra Ab: Deals, January 2021-June 2024
Table 317 Sectra Ab: Other Developments, January 2021-June 2024
Table 318 Akoya Biosciences, Inc.: Company Overview
Table 319 Akoya Biosciences, Inc.: Products Offered
Table 320 Akoya Biosciences, Inc.: Product Launches & Approvals, January 2021-June 2024
Table 321 Akoya Biosciences, Inc.: Deals, January 2021-June 2024
Table 322 Fujifilm Holdings Corporation: Company Overview
Table 323 Fujifilm Holdings Corporation: Products Offered
Table 324 Fujifilm Holdings Corporation: Deals, January 2021-June 2024
Table 325 Hologic, Inc.: Company Overview
Table 326 Hologic, Inc.: Products Offered
Table 327 Hologic, Inc.: Product Approvals, January 2021-June 2024
Table 328 3Dhistech Ltd.: Company Overview
Table 329 3Dhistech Ltd.: Products Offered
Table 330 3Dhistech Ltd.: Product Launches & Enhancements, January 2021-June 2024
Table 331 3Dhistech Ltd.: Other Developments, January 2021-June 2024
Table 332 Apollo Enterprise Imaging Corp.: Company Overview
Table 333 Apollo Enterprise Imaging Corp.: Products Offered
Table 334 Apollo Enterprise Imaging Corp.: Product Enhancements, January 2021-June 2024
Table 335 Apollo Enterprise Imaging Corp.: Deals, January 2021-June 2024
Table 336 Xifin, Inc.: Company Overview
Table 337 Xifin, Inc.: Products Offered
Table 338 Xifin, Inc.: Product Launches, January 2021-June 2024
Table 339 Xifin, Inc.: Deals, January 2021-June 2024
Table 340 Huron Digital Pathology: Company Overview
Table 341 Huron Digital Pathology: Products Offered
Table 342 Huron Digital Pathology: Product Approvals, January 2021-June 2024
Table 343 Huron Digital Pathology: Deals, January 2021-June 2024
Table 344 Huron Digital Pathology: Other Developments, January 2021-June 2024
Table 345 Corista: Company Overview
Table 346 Corista: Products Offered
Table 347 Corista: Deals, January 2021-June 2024
Table 348 Corista: Other Developments, January 2021-June 2024
Table 349 Indica Labs: Company Overview
Table 350 Indica Labs: Products Offered
Table 351 Indica Labs: Product Launches & Approvals, January 2021-June 2024
Table 352 Indica Labs: Deals, January 2021-June 2024
Table 353 Objective Pathology Services: Company Overview
Table 354 Objective Pathology Services: Products Offered
Table 355 Optrascan, Inc.: Company Overview
Table 356 Optrascan, Inc.: Products Offered
Table 357 Optrascan, Inc.: Product Launches & Approvals, January 2021-June 2024
Table 358 Optrascan, Inc.: Deals, January 2021-June 2024
Table 359 Glencoe Software, Inc.: Company Overview
Table 360 Glencoe Software, Inc.: Products Offered
Table 361 Glencoe Software, Inc.: Product Enhancements, January 2021-June 2024
Table 362 Aiforia Technologies Oy: Company Overview
Table 363 Aiforia Technologies Oy: Products Offered
Table 364 Aiforia Technologies Oy: Deals, January 2021-June 2024
Table 365 Paige AI, Inc.: Company Overview
Table 366 Paige AI, Inc.: Products Offered
Table 367 Paige AI, Inc.: Product Launches & Enhancements, January 2021-June 2024
Table 368 Paige AI, Inc.: Deals, January 2021-June 2024
Table 369 Proscia, Inc.: Company Overview
Table 370 Proscia, Inc.: Products Offered
Table 371 Proscia, Inc.: Product Enhancements & Approvals, January 2021-June 2024
Table 372 Proscia, Inc.: Deals, January 2021-June 2024

Figure 1 Digital Pathology Market
Figure 2 Research Design
Figure 3 Primary Sources
Figure 4 Breakdown of Primary Interviews: by Demand Side, Supply Side, Designation, and Region
Figure 5 Research Methodology: Hypothesis Building
Figure 6 Market Size Estimation: Revenue Share Analysis
Figure 7 Digital Pathology Market: Revenue Share Analysis Illustration of Danaher Corporation
Figure 8 Bottom-Up Approach
Figure 9 CAGR Projections: Supply-Side Analysis
Figure 10 CAGR Projections from Analysis of Drivers, Restraints, Opportunities, and Challenges in Digital Pathology Market (2024-2029)
Figure 11 Data Triangulation Methodology
Figure 12 Digital Pathology Market, by Product, 2024 vs. 2029 (USD Million)
Figure 13 Digital Pathology Market, by Type, 2024 vs. 2029 (USD Million)
Figure 14 Digital Pathology Market, by Application, 2024 vs. 2029 (USD Million)
Figure 15 Digital Pathology Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 16 Geographic Snapshot of Digital Pathology Market
Figure 17 Rising Incidence of Cancer and Growing Adoption of Pathology Solutions for Enhanced Lab Efficiency to Drive Market
Figure 18 Pharmaceutical & Biotechnology Companies Accounted For Largest Market Share in 2023
Figure 19 UK to Grow at Highest CAGR During Forecast Period
Figure 20 Asia-Pacific Segment to Dominate Market During Forecast Period
Figure 21 Digital Pathology Market: Drivers, Restraints, Opportunities, And Challenges
Figure 22 Global Cancer Incidence, 2008-2030
Figure 23 FDA-Approved Personalized Medicines, 2015-2021
Figure 24 Digital Pathology Market: Value Chain Analysis
Figure 25 Digital Pathology Market: Ecosystem Analysis
Figure 26 Digital Pathology Market: Porter's Five Forces Analysis
Figure 27 Europe: Ivdr Timeline
Figure 28 Jurisdiction Analysis: Top Applicant Countries for Digital Pathology Patents, 2013-2023
Figure 29 Major Patents for Digital Pathology (2013-2023)
Figure 30 Key Buying Criteria for Digital Pathology Products
Figure 32 Market Potential of Generative AI in Enhancing Digital Pathology Across Industries
Figure 33 Impact of Gen AI on Interconnected and Adjacent Ecosystems
Figure 34 North America: Digital Pathology Market Snapshot
Figure 35 Europe: Digital Pathology Market Snapshot
Figure 36 Revenue Analysis of Key Players in Digital Pathology Market
Figure 37 Digital Pathology Market: Market Share Analysis (2023)
Figure 38 Digital Pathology Market: Company Evaluation Matrix (Key Players), 2023
Figure 39 Digital Pathology Market: Company Footprint
Figure 40 Digital Pathology Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 41 EV/EBITDA of Key Vendors
Figure 42 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Digital Pathology Vendors
Figure 43 Danaher Corporation: Company Snapshot (2023)
Figure 44 Koninklijke Philips N.V.: Company Snapshot (2023)
Figure 45 Hamamatsu Photonics K.K.: Company Snapshot (2023)
Figure 46 F. Hoffmann-La Roche Ltd.: Company Snapshot (2023)
Figure 47 Sectra Ab.: Company Snapshot (2023)
Figure 48 Akoya Biosciences, Inc.: Company Snapshot (2023)
Figure 49 Fujifilm Holdings Corporation: Company Snapshot (2022)
Figure 50 Hologic, Inc.: Company Snapshot (2023)